Adam Szpechcinski
- Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patientsBy Radoslaw Struniawski, Pawel Kuca, Adam Szpechcinski, Michal Skronski, Malgorzata Czajkowska-Malinowska, Jerzy Kozielski, Pawel Sliwinski, Katarzyna Gόrska, Piotr Korczynski, Rafal Krenke, Ryszarda Chazan, Urszula Oldakowska-Jedynak, Marek Krawczyk, Ewa Jassem, Halina Batura-Gabryel and Joanna Chorostowska-WynimkoRadoslaw Struniawski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPawel Kuca1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMalgorzata Czajkowska-Malinowska3Department of Lung Diseases and Respiratory Failure, Regional Center of Pulmonology, Bydgoszcz, PolandJerzy Kozielski4Department of Lung Diseases and Tuberculosis, Silesian Medical University, Zabrze, PolandPawel Sliwinski5Department of Diagnosis and Treatment of Respiratory Failure, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKatarzyna Gόrska2Department of Internal Medicine, Pneumology and Allergology, Medical University of Warsaw, Warsaw, PolandPiotr Korczynski2Department of Internal Medicine, Pneumology and Allergology, Medical University of Warsaw, Warsaw, PolandRafal Krenke2Department of Internal Medicine, Pneumology and Allergology, Medical University of Warsaw, Warsaw, PolandRyszarda Chazan2Department of Internal Medicine, Pneumology and Allergology, Medical University of Warsaw, Warsaw, PolandUrszula Oldakowska-Jedynak7Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, PolandMarek Krawczyk7Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, PolandEwa Jassem6Department of Allergology, Medical University of Gdansk, Gdansk, PolandHalina Batura-Gabryel8Department of Pulmonary, Allergology and Respiratory Oncology, Poznan University of Medical Sciences, Poznan, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)By Andrzej Dyczek, Jerzy Szczeklik, Barbara Balicka-Slusarczyk, Joanna Chorostowska, Adam Szpechcinski, Ewelina Pόlgesek, Marek Jankowski and Piotr KopinskiAndrzej Dyczek1II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandJerzy Szczeklik1II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandBarbara Balicka-Slusarczyk2Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandJoanna Chorostowska3Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAdam Szpechcinski3Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandEwelina Pόlgesek4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Evaluation of highly sensitive PNA-LNA PCR clamp method for EGFR L858R mutation detection in lung adenocarcinoma patientsBy Michal Skronski, Tomoaki Tanaka, Adam Szpechcinski, Renata Langfort, Tadeusz Orlowski, Koichi Hagiwara and Joanna Chorostowska-WynimkoMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTomoaki Tanaka4Department of Respiratory Medicine, Saitama Medical University, Moroyama-machi, Saitama, JapanAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski3Department of Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKoichi Hagiwara4Department of Respiratory Medicine, Saitama Medical University, Moroyama-machi, Saitama, JapanJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL formBy Piotr Kopinski, Andrzej Dyczek, Barbara Balicka-Slusarczyk, Grzegorz Przybylski, Joanna Chorostowska-Wynimko, Adam Szpechcinski, Teresa Iwaniec, Karina Szablowska and Jerzy SzczeklikPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAndrzej Dyczek2II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandBarbara Balicka-Slusarczyk3Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandGrzegorz Przybylski5Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko4Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAdam Szpechcinski4Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandTeresa Iwaniec1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandKarina Szablowska1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJerzy Szczeklik3Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, Poland
- The clinical significance of plasma DNA quantification in NSCLCBy Adam Szpechcinski, Krystyna Maszkowska-Kopij, Wlodzimierz Kupis, Jolanta Zaleska, Elzbieta Radzikowska, Radoslaw Struniawski, Elzbieta Puscinska, Tadeusz Orlowski, Pawel Sliwinski, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij2Outpatient Clinic, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandWlodzimierz Kupis3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska5III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandElzbieta Radzikowska5III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRadoslaw Struniawski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandElzbieta Puscinska4II Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPawel Sliwinski6Department of Diagnosis and Treatment of Respiratory Failure, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz5III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Diverse effects of PAI-1 proteins on lung and prostate cancer cell invasionBy Adriana Rozy, Marta Kedzior, Joanna Chorostowska-Wynimko, Paulina Jagus, Adam Szpechcinski, Ewa Skrzypczak-Jankun and Jerzy JankunAdriana Rozy1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMarta Kedzior1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandEwa Skrzypczak-Jankun2Urology Research Center, University of Toledo, Medical Center, Toledo, OH, United StatesJerzy Jankun2Urology Research Center, University of Toledo, Medical Center, Toledo, OH, United States
- Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cellsBy Adriana Rozy, Marta Kedzior, Joanna Chorostowska-Wynimko, Paulina Jagus, Adam Szpechcinski, Ewa Skrzypczak-Jankun and Jerzy JankunAdriana Rozy1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMarta Kedzior1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandEwa Skrzypczak-Jankun2Urology Research Center, University of Toledo, Medical Center, Toledo, OH, United StatesJerzy Jankun2Urology Research Center, University of Toledo, Medical Center, Toledo, OH, United States
- Rapid DNA extraction from dried blood spots for the alpha-1 antitrypsin deficiency detection by real-time PCRBy Radoslaw Struniawski, Adam Szpechcinski, Beata Poplawska, Michal Skronski, Pawel Kuca and Joanna Chorostowska-WynimkoRadoslaw Struniawski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandBeata Poplawska1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPawel Kuca1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Evaluation of PNA-LNA PCR clamp method sensitivity for detection of key EGFR gene exon 19 and exon 21 mutationsBy Michal Skronski, Adam Szpechcinski, Paulina Jagus, Tomoaki Tanaka, Radoslaw Struniawski, Koichi Hagiwara and Joanna Chorostowska-WynimkoMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTomoaki Tanaka2Department of Respiratory Medicine, Saitama Medical University, Moroyama-machi, Saitama, JapanRadoslaw Struniawski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKoichi Hagiwara2Department of Respiratory Medicine, Saitama Medical University, Moroyama-machi, Saitama, JapanJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Interleukin 27 (IL27): A new tool for lung cancer gene immunotherapy?By Tomasz Wandtke, Marek Jankowski, Piotr Kopinski, Mariusz Bella, Janusz Kowalewski, Adam Szpechcinski and Ewelina PólgesekTomasz Wandtke1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMariusz Bella2Dept. of Chest and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJanusz Kowalewski2Dept. of Chest and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAdam Szpechcinski3Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandEwelina Pólgesek1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells contentBy Michal Skronski, Renata Langfort, Krystyna Maszkowska-Kopij, Paulina Jagus, Adam Szpechcinski, Tomoaki Tanaka, Tadeusz Orlowski, Koichi Hagiwara and Joanna Chorostowska-WynimkoMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij3Outpatients Department, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTomoaki Tanaka4Department of Respiratory Medicine, Saitama Medical University, Moroyama-Machi, Saitama, JapanTadeusz Orlowski5Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKoichi Hagiwara4Department of Respiratory Medicine, Saitama Medical University, Moroyama-Machi, Saitama, JapanJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Plasma DNA concentration and integrity measurement for NSCLC diagnostics and radical therapy effectiveness monitoringBy Adam Szpechcinski, Joanna Chorostowska-Wynimko, Wlodzimierz Kupis, Krystyna Maszkowska-Kopij, Jolanta Zaleska, Elzbieta Radzikowska, Elzbieta Puscinska, Pawel Sliwinski, Tadeusz Orlowski and Kazimierz Roszkowski-SlizAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandWlodzimierz Kupis2Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij3Outpatient Clinic, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska4Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandElzbieta Radzikowska4Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandElzbieta Puscinska5Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPawel Sliwinski6Department of Diagnosis and Treatment of Respiratory Failure, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski2Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz4Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimensBy Michal Skronski, Paulina Jagus, Renata Langfort, Adam Szpechcinski, Krystyna Maszkowska-Kopij, Barbara Roszkowska-Sliz, Jacek Grudny, Jolanta Zaleska, Tadeusz Orlowski, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij3Outpatient Clinic, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandBarbara Roszkowska-Sliz4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJacek Grudny4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski5Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Accurate and reliable determination of α1-antitrypsin levels in respiratory patients using dried blood spot specimensBy Radoslaw Struniawski, Adam Szpechcinski, Beata Poplawska, Michal Skronski, Pawel Kuca and Joanna Chorostowska-WynimkoRadoslaw Struniawski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandBeata Poplawska1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMichal Skronski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPawel Kuca1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseasesBy Andrzej Dyczek, Piotr Kopinski, Joanna Chorostowska-Wynimko, Krzysztof Sladek, Jerzy Soja, Cezary Rybacki, Iwona Patyk and Adam SzpechcinskiAndrzej Dyczek1II Dept. of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandPiotr Kopinski2Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko3Dept. of Molecular Biology and Immunology, Inst. of Tuberculosis and Lung Diseases, Warszawa, PolandKrzysztof Sladek1II Dept. of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandJerzy Soja1II Dept. of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandCezary Rybacki4Pulmonology and Allergy Clinical Ward, 10 Military Research Hospital and Polyclinic, Bydgoszcz, PolandIwona Patyk4Pulmonology and Allergy Clinical Ward, 10 Military Research Hospital and Polyclinic, Bydgoszcz, PolandAdam Szpechcinski3Dept. of Molecular Biology and Immunology, Inst. of Tuberculosis and Lung Diseases, Warszawa, Poland
- Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patientsBy Tomasz Wandtke, Joanna Chorostowska-Wynimko, Adam Szpechcinski, Grzegorz Przybylski, Agnieszka Jarzemska, Ewelina Wedrowska, Agata Gizycka, Joanna Wielikdzien and Piotr KopinskiTomasz Wandtke1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warsaw, PolandGrzegorz Przybylski3Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAgnieszka Jarzemska3Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandEwelina Wedrowska1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAgata Gizycka1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Wielikdzien1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Plasma cell-free DNA concentration and integrity analysis in patients with chest radiological findings: NSCLC versus non-malignant pathologiesBy Adam Szpechcinski, Wlodzimierz Kupis, Renata Langfort, Jolanta Zaleska, Krystyna Maszkowska-Kopij, Tadeusz Orlowski, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoAdam Szpechcinski1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandWlodzimierz Kupis2Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort3Department of Pathomorphology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij5Outpatient Clinic, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski2Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot studyBy Adam Szpechcinski, Monika Gos, Radoslaw Struniawski, Michal Skronski, Wlodzimierz Kupis, Piotr Rudzinski, Renata Langfort, Jolanta Zaleska, Krystyna Maszkowska-Kopij, Tadeusz Orlowski, Jerzy Bal, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoAdam Szpechcinski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMonika Gos2Department of Medical Genetics, National Research Institute of Mother and Child, Warsaw, PolandRadoslaw Struniawski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMichal Skronski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandWlodzimierz Kupis3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPiotr Rudzinski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort4Department of Pathomorphology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska5III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij6Outpatient Clinic, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJerzy Bal2Department of Medical Genetics, National Research Institute of Mother and Child, Warsaw, PolandKazimierz Roszkowski-Sliz5III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- The phenotypes and serum levels of alpha-1 antitrypsin in lung cancer patients – Preliminary resultsBy Adam Szpechcinski, Radoslaw Struniawski, Beata Poplawska-Wisniewska, Dorota Giedronowicz, Wlodzimierz Kupis, Piotr Rudzinski, Jolanta Zaleska, Renata Langfort, Tadeusz Orlowski, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoAdam Szpechcinski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRadoslaw Struniawski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandBeata Poplawska-Wisniewska1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandDorota Giedronowicz2Departemt of Pathomorphology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandWlodzimierz Kupis3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPiotr Rudzinski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Departemt of Pathomorphology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz4III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Immunohistochemistry versus DNA testing for detection of EGFR mutations and ALK rearrangements in lung adenocarcinoma patientsBy Michal Skronski, Renata Langfort, Dorota Giedronowicz, Paulina Jagus, Adam Szpechcinski and Joanna Chorostowska-WynimkoMichal Skronski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandDorota Giedronowicz2Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimensBy Michal Skronski, Renata Langfort, Paulina Jagus, Adam Szpechcinski, Krystyna Maszkowska-Kopij, Tadeusz Orlowski, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoMichal Skronski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Department of Pathology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPaulina Jagus1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKrystyna Maszkowska-Kopij3Outpatient Clinic, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski4Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz5III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Assessment of neutrophil serine proteinases activity in bronchoalveolar lavage fluids from patients with interstitial lung diseases using innovative intramolecular quenched substratesBy Beata Poplawska-Wisniewska, Jadwiga Popow-Stellmaszyk, Radoslaw Struniawski, Magdalena Wysocka, Adam Lesner, Adam Szpechcinski and Joanna Chorostowska-WynimkoBeata Poplawska-Wisniewska1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJadwiga Popow-Stellmaszyk2Department of Chemistry, University of Gdansk, Gdansk, PolandRadoslaw Struniawski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandMagdalena Wysocka2Department of Chemistry, University of Gdansk, Gdansk, PolandAdam Lesner2Department of Chemistry, University of Gdansk, Gdansk, PolandAdam Szpechcinski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- The evaluation of biological and clinical significance of alpha-1 antitrypsin in non-small cell lung cancerBy Adam Szpechcinski, Beata Poplawska-Wisniewska, Emilia Debek, Renata Langfort, Dorota Giedronowicz, Radoslaw Struniawski, Wlodzimierz Kupis, Piotr Rudzinski, Jolanta Zaleska, Pawel Sliwinski, Tadeusz Orlowski, Kazimierz Roszkowski-Sliz and Joanna Chorostowska-WynimkoAdam Szpechcinski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandBeata Poplawska-Wisniewska1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandEmilia Debek1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRenata Langfort2Department of Pathomorphology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandDorota Giedronowicz2Department of Pathomorphology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandRadoslaw Struniawski1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandWlodzimierz Kupis3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPiotr Rudzinski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJolanta Zaleska4Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandPawel Sliwinski4Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandTadeusz Orlowski3Department of Thoracic Surgery, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandKazimierz Roszkowski-Sliz4Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
- Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA moleculesBy Maciej Gawronski, Piotr Kopinski, Marek Jankowski, Arkadiusz Goede, Adam Szpechcinski and Joanna ChorostowskaMaciej Gawronski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski2Dept of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandArkadiusz Goede1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAdam Szpechcinski3Dept of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warszawa, PolandJoanna Chorostowska3Dept of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warszawa, Poland
- Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)By Piotr Kopinski, Joanna Chorostowska, Grzegorz Przybylski, Andrzej Dyczek, Ewelina Wedrowska, Marek Jankowski, Adam Szpechcinski, Agata Gizycka and Joanna GolinskaPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska2Dept of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandGrzegorz Przybylski3Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAndrzej Dyczek4The Cardiology Outpatient Clinic, John Paul II Hospital, Krakow, PolandEwelina Wedrowska1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski5Dept of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAdam Szpechcinski2Dept of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAgata Gizycka2Dept of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandJoanna Golinska1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
